SCHEMBL21091024

SCHEMBL21091024

Cc1ncccc1-c1cscn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP6 P55212 1/20 0.45
IDO1 P14902 5/20 0.43
TDO2 P48775 4/20 0.43
METAP2 P50579 3/20 0.41
METAP1 P53582 3/20 0.41
PDE2A O00408 1/20 0.39
PDE4D Q08499 1/20 0.39
PDE3A Q14432 1/20 0.39
PDE10A Q9Y233 1/20 0.39
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 1/20 0.39
GRK5 P34947 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
ADORA3 P0DMS8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14754342 0.81 CASP6 (0.48) CASP6IDO1TDO2METAP2METAP1
SCHEMBL4533718 0.78 CASP6 (0.45) CASP6IDO1TDO2METAP2METAP1
SCHEMBL29430087 0.77 METAP2 (0.46) IDO1TDO2METAP2METAP1TSHR
SCHEMBL4533675 0.77 METAP2 (0.46) IDO1TDO2METAP2METAP1TSHR
SCHEMBL21777129 0.75 IDO1 (0.45) CASP6IDO1TDO2TDP1KDM4A
SCHEMBL31469002 0.75 MKNK1 (0.52) TDO2PDE2APDE4DPDE3APDE10A
SCHEMBL3421959 0.75 MKNK1 (0.52) TDO2PDE2APDE4DPDE3APDE10A
SCHEMBL26259974 0.74 SCN9A (0.43) CASP6IDO1TDO2METAP2METAP1
SCHEMBL10151023 0.73 MPL (0.50) CASP6IDO1TDO2METAP2METAP1
SCHEMBL27545633 0.73 METAP1 (0.40) CASP6IDO1TDO2METAP2METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495358-A1 AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES Bristol-Myers Squibb Company (US) 2019-06-12 EP disclosed